Evidence map›Paper›PMID 39754490›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

Recibokibart, an anti-IL-36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial.

Qiaoxia Qian, Baoqi Yang, Xueyan Lu, Zhaoxia Zhang, Jiaqi Chen, Yehong Kuang, Chunlei Zhang, Xiaoyong Man, Juan Su, Chi Ma and 12 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Qiaoxia QianDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.ORCID https://orcid.org/0000-0001-9592-7447
Baoqi YangHospital for Skin Diseases, Shandong First Medical University, Shandong, China.ORCID https://orcid.org/0000-0003-3521-7130
Xueyan LuPeking University Third Hospital, Beijing, China.
Zhaoxia ZhangHospital for Skin Diseases, Shandong First Medical University, Shandong, China.ORCID https://orcid.org/0000-0001-9796-3660
Jiaqi ChenDepartment of Dermatology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
Yehong KuangXiangya Hospital Central South University, Changsha, China.ORCID https://orcid.org/0000-0002-1133-1791
Chunlei ZhangPeking University Third Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-8699-6691
Xiaoyong ManDepartment of Dermatology, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0000-0003-3331-5538
Juan SuXiangya Hospital Central South University, Changsha, China.
Chi MaDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Guodong ZhouDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Benke LiDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Xiaolu SituDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Xiuqiang MaDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Yongming YangDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Yujie FengDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.ORCID https://orcid.org/0009-0001-6599-0629
Shi ChenDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Yifan ZhanDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.ORCID https://orcid.org/0000-0002-2308-8864
Qian ChenDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Xiangyang ZhuDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.
Jiucun WangState Key Laboratory of Genetic Engineering, School of Life Sciences and Human Phenome Institute, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0003-2765-0620
Furen ZhangHospital for Skin Diseases, Shandong First Medical University, Shandong, China.ORCID https://orcid.org/0000-0002-3383-1973

Funding

Shanghai Huaota Biopharmaceutical
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39754490
PMCPMC12105414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.